Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lamond David
Director at Quince Therapeutics. Filing since 15 May 2020.
CIK 0001770790
Company
Date
Role
Action
Shares
Amount
Of holding
QNCX
Quince Therapeutics, Inc.
14 Dec 2023
Director
Bought
22,627
$23.53K
1.0%
QNCX
Quince Therapeutics, Inc.
13 Dec 2023
Director
Bought
22,627
$22.63K
1.0%
QNCX
Quince Therapeutics, Inc.
12 Dec 2023
Director
Bought
22,327
$22.77K
1.0%
QNCX
Quince Therapeutics, Inc.
12 Dec 2023
Director
Bought
300
$300.00
0.0%
QNCX
Quince Therapeutics, Inc.
7 Dec 2023
Director
Bought
19,123
$19.31K
0.8%
QNCX
Quince Therapeutics, Inc.
6 Dec 2023
Director
Bought
19,123
$19.51K
0.9%
QNCX
Quince Therapeutics, Inc.
5 Dec 2023
Director
Bought
19,123
$19.31K
0.9%
QNCX
Quince Therapeutics, Inc.
1 Dec 2023
Director
Bought
14,378
$13.52K
0.7%
QNCX
Quince Therapeutics, Inc.
30 Nov 2023
Director
Bought
14,378
$12.94K
0.7%
QNCX
Quince Therapeutics, Inc.
29 Nov 2023
Director
Bought
14,378
$14.09K
0.7%
QNCX
Quince Therapeutics, Inc.
31 Aug 2023
Director
Bought
41,026
$54.15K
1.9%
QNCX
Quince Therapeutics, Inc.
30 Aug 2023
Director
Bought
41,026
$53.74K
2.0%
QNCX
Quince Therapeutics, Inc.
17 Aug 2023
Director
Bought
24,766
$31.95K
1.2%
QNCX
Quince Therapeutics, Inc.
16 Aug 2023
Director
Bought
117,348
$151.38K
6.0%
QNCX
Quince Therapeutics, Inc.
15 Aug 2023
Director
Bought
107,886
$142.41K
5.8%
QNCX
Quince Therapeutics, Inc.
24 Mar 2021
Director
Bought
50,000
$1.69M
2.8%
QNCX
Quince Therapeutics, Inc.
4 Mar 2021
Director
Bought
50,000
$1.77M
2.9%
QNCX
Quince Therapeutics, Inc.
4 Jun 2020
Director
Bought
49,125
$2.13M
2.9%
QNCX
Quince Therapeutics, Inc.
19 May 2020
Director
Bought
39,200
$2.20M
2.4%
QNCX
Quince Therapeutics, Inc.
15 May 2020
Director
Bought
5,448
$266.57K
0.3%
20 decisions on file.
